Analystreport

Akebia Therapeutics Inc (NASDAQ: AKBA) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.

Akebia Therapeutics, Inc.  (AKBA) 
Last akebia therapeutics, inc. earnings: 3/10 07:49 am Check Earnings Report
US:NASDAQ Investor Relations: ir.akebia.com/investor-relations